The Human Genome Project of the 1990s has enhanced the drug discovery process and reduced the cost for developing medicines. By taking advantage of the vast amount of data and bioinformatics software tools generated by the genome project, our scientific founders have instigated research programs in the areas of cancer and inflammation. Our high-quality, cost-efficient discovery programs are our global competitive advantage.